BioCentury | Mar 30, 2009
Company News

Abeille, ProStrakan deal

...transdermal granisetron patch has completed Phase I trials to treat chemotherapy-induced nausea and vomiting (CINV). ProStrakan said AB-1001...
...can deliver the same dosage of granisetron in a smaller patch than its marketed Sancuso transdermal granisetron patch...
...were not disclosed. SymBio Pharmaceuticals Ltd. (Tokyo, Japan) has rights to AB-1001, which it calls SyB D-0701...
BioCentury | Mar 23, 2009
Company News

EKR, ProStrakan sales and marketing update

...Healthcare S.A. (Pazzallo, Switzerland). ProStrakan's sales force will market Gelclair to oncologists alongside its Sancuso transdermal granisetron patch...
BioCentury | Sep 22, 2008
Clinical News

Sancuso regulatory update

...for Sancuso to prevent chemotherapy-induced nausea and vomiting (CINV). The company plans to launch the transdermal granisetron patch...
BioCentury | Sep 22, 2008
Finance

Shaking in their shorts

...for Sancuso to prevent chemotherapy-induced nausea and vomiting (CINV). The company plans to launch the transdermal granisetron patch...
BioCentury | Sep 16, 2008
Company News

FDA approves Sancuso for CINV

...for Sancuso to prevent chemotherapy-induced nausea and vomiting (CINV). The company plans to launch the transdermal granisetron patch...
BioCentury | Sep 1, 2008
Strategy

Back to School 2008: Adversity & acclimatization

...Corp., and ProStrakan Group plc to smooth the U.S. commercialization of the British company’s Sancuso transdermal granisetron patch...
BioCentury | Aug 4, 2008
Clinical News

SyB D-0701: Phase I completed

...as AB-1001. Abeille Pharmaceuticals Inc. , Princeton, N.J. SymBio Pharmaceuticals Ltd. , Tokyo, Japan Product: SyB D-0701...
...Abeille Pharmaceuticals Inc. , Princeton, N.J. SymBio Pharmaceuticals Ltd. , Tokyo, Japan Product: SyB D-0701 ( AB-1001...
BioCentury | Jul 21, 2008
Clinical News

Sancuso regulatory update

...pushed back to July 18 (see BioCentury, July 14). ProStrakan still plans to launch the transdermal granisetron patch...
BioCentury | Jul 21, 2008
Finance

Ebb & Flow

...the agency. The company expects a decision this quarter and still plans to launch the transdermal granisetron patch...
BioCentury | Jul 18, 2008
Company News

FDA delays Sancuso PDUFA again

...Friday. The original PDUFA date was May 2. The company still plans to launch the transdermal granisetron patch...
Items per page:
1 - 10 of 26